Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M

In a case so old that it predates Pfizer’s 2009 acquisition of Wyeth, the companies and a class-action group of direct drug purchasers have agreed to settle an antitrust claim for $39 million.